Technical Analysis for ACHN - Achillion Pharmaceuticals, Inc.

Grade Last Price % Change $ Change
grade F $4.20 -1.18% -0.05
ACHN closed down 1.18 percent on Friday, January 13, 2017, on 54 percent of normal volume. It ran into resistance at its 50 day moving average.
Track This Stock
Watchlist Portfolio
Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical ACHN trend table...

Date Alert Name Type % Chg
Jan 13 50 DMA Resistance Bearish 0.00%
Jan 11 Expansion Pivot Sell Setup Bearish Swing Setup 0.24%
Jan 11 Stochastic Sell Signal Bearish 0.24%
Jan 11 Fell Below 50 DMA Bearish 0.24%
Jan 10 Crossed Above 50 DMA Bullish -6.04%
Jan 9 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -6.04%
Jan 9 Stochastic Reached Overbought Other -6.04%
Jan 9 50 DMA Resistance Bearish -6.04%
Jan 6 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -5.62%
Jan 6 New Uptrend Bullish -5.62%

Older signals for ACHN ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.

Achillion Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes anti-infective drug therapies in the United States and internationally. It focuses on the development of antivirals for the treatment of chronic hepatitis C viral (HCV) infection. The company’s drug candidates for treating chronic HCV infection comprise Sovaprevir, a NS3 protease inhibitor, which has completed a Phase IIa clinical trial; ACH-3102, a NS5A inhibitor that is in Phase IIa clinical trial; and ACH-2684, a NS3 protease inhibitor, which has completed Phase Ia and 1b clinical trials. Its pipeline of antibacterial product candidates includes ACH-702 for the treatment of dermatologic and ophthalmic infections; and ACH-2881 for the treatment of serious resistant bacterial infections, including methicillin-resistant staphylococcus aureus. The company was founded in 1998 and is headquartered in New Haven, Connecticut.
Is ACHN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 10.06
52 Week Low 3.78
Average Volume 2,428,910
200-Day Moving Average 7.33
50-Day Moving Average 4.33
20-Day Moving Average 4.22
10-Day Moving Average 4.3
Average True Range 0.24
ADX 21.06
+DI 19.75
-DI: 21.32
Chandelier Exit (Long, 3 ATRs) 3.88
Chandelier Exit (Short, 3 ATRs) 4.66
Upper Bollinger Band 4.5
Lower Bollinger Band 3.94
Percent B (%b) 0.46
Bandwidth 0.132701